Equity

SHSCX

Health Sciences Opportunities Fund

Overview

Loading

Performance

Performance

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted. The performance information for periods prior to the inception date of the share class are based on the Fund’s Investor A Shares, adjusted to reflect the fees and expenses applicable to such share class. See the fund prospectus for more details.

Growth of Hypothetical $10,000 The growth of hypothetical $10,000 chart reflects a hypothetical $10,000 investment and assumes reinvestment of dividends and capital gains. Fund expenses, including management fees and other expenses were deducted.

Performance chart data not available for display.
View full chart

Distributions

Interactive chart displaying fund performance. Javascript is required.

View full chart

Key Facts

Key Facts

Size of Class (Millions) as of Jul 08, 2020 $819.4 M
Size of Fund (Millions) as of Jul 08, 2020 $9,217.4 M
Share Class launch date Oct 16, 2000
Asset Class Equity
Morningstar Category Health
Lipper Classification Health/Biotech Funds
Benchmark Index Russell 3000 HealthCare Index
CUSIP 091937557
Number of Holdings as of Jun 30, 2020 118
Max Offer Price as of Jul 08, 2020 $59.05
Open to New Investors Yes
Turnover Percent in the Annual Report as of Jun 30, 2020 41%

Portfolio Characteristics

Portfolio Characteristics

Average Market Cap (Millions) The average size of the securities the fund invests in. as of Jun 30, 2020 $ 100,145.5 M
R-Squared (3y) as of May 31, 2020 97.34
Beta (3y) as of May 31, 2020 0.94
Best 3-Month Return Over the Last 3 Years 3 months ending Jun 30, 2020 17.26%
Worst 3-Month Return Over the Last 3 Years 3 months ending Mar 31, 2020 -11.69%
Fund Standard Deviation (3y) as of May 31, 2020 15.44

This information must be preceded or accompanied by a current prospectus. For standardized performance, please see the Performance section above.

Ratings

Ratings

Morningstar Rating

4
Overall Morningstar Rating for Health Sciences Opportunities Fund, Class C, as of Jun 30, 2020 rated against 135 Health Funds based on risk adjusted total return.

Holdings

Holdings

as of Jun 30, 2020
Name Weight (%)
UNITEDHEALTH GROUP INC 6.94
ABBOTT LABORATORIES 4.70
JOHNSON & JOHNSON 4.52
THERMO FISHER SCIENTIFIC INC 2.93
AMGEN INC 2.88
Name Weight (%)
BOSTON SCIENTIFIC CORPORATION 2.78
VERTEX PHARMACEUTICALS INCORPORATED 2.57
MEDTRONIC PLC 2.57
HUMANA INC 2.56
ELI LILLY AND COMPANY 2.55

Exposure Breakdowns

Exposure Breakdowns

as of Jun 30, 2020

% of Market Value

Type Fund Benchmark Net
as of Jun 30, 2020

% of Market Value

Type Fund Benchmark Net
as of Jun 30, 2020

% of Market Value

Type Fund Benchmark Net
as of Jun 30, 2020

% of Market Value

Type Fund Benchmark Net
Negative weightings may result from specific circumstances (including timing differences between trade and settle dates of securities purchased by the funds) and/or the use of certain financial instruments, including derivatives, which may be used to gain or reduce market exposure and/or risk management.

Allocations are subject to change.

Portfolio Managers

Portfolio Managers

Erin Xie
Head of the Health Sciences team

  

Xiang Liu
BlackRock Health Sciences Team

Xiang Liu, PhD, Director, is a member of the Health Sciences team, part of Blackrock's Active Equity Group. He is a co-portfolio manager for the Health Sciences equity portfolios and is responsible for coverage of the medical devices sector.

Jeffrey Lee
BlackRock Health Sciences Team

Jeffrey Lee, Vice President, is a member of the Health Sciences team, part of BlackRock's Active Equity Group. He is a co-portfolio manager for the Health Sciences equity portfolios and is responsible for coverage of the healthcare providers and services sectors.

Portfolio Manager

Literature

Literature

 

There are many ways to access BlackRock Funds, learn how you can add them to your portfolio